Science Abstracts
RELATED CONTENT
NEWS
- EMA reviews CV risk in NSAIDs and cancer risk in Protelos; concludes ARB review
- A year in pharma and biotech R&D: Healthy numbers belie lack of novelty
- US FDA OK's Horizon Pharma's arthritis drug Duexis
- Will Berinert's US OK for self-administration put Shire's Firazyr on the run?
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here


